sections
As a result of the financial performance for the year 2021, the AACR’s net unrestricted net assets are now $155 million. These positive financial results allow the AACR to continue strategic investments in its mission-driven activities to prevent and cure all cancers.
2021 TOTAL EXPENSES
Note: Totals may not equal 100% due to rounding.
2021 PROGRAM EXPENSES
Unrestricted Revenues and Expenses (Unaudited)
As of December 31, 2021
2020 | 2021 | 2021 Percent of Total | ||||
REVENUE | ||||||
Membership Dues | $4,208,008 | $4,273,800 | 6% | |||
Publications | $18,928,229 | $19,781,338 | 27% | |||
Scientific Meetings and Educational Workshops | $3,163,862 | $14,703,304 | 20% | |||
Other Revenue | $10,007,708 | $5,818,466 | 8% | |||
Subtotal Program Revenue | $36,307,807 | $44,576,908 | 61% | |||
Support | ||||||
NIH Grants | $115,500 | $482,635 | 1% | |||
Contributions | $51,093,657 | $28,310,646 | 39% | |||
Subtotal Support Revenue | $51,209,157 | $28,793,281 | 39% | |||
TOTAL REVENUE | $87,516,964 | $73,370,189 | 100% | |||
EXPENSES | ||||||
Research Grants and Scientific Awards | $45,519,345 | $22,524,121 | 33% | |||
Scientific Meetings and Educational Workshops | $11,474,114 | $9,064,752 | 13% | |||
Scientific Publications | $12,840,789 | $13,437,611 | 20% | |||
Communications, Science Policy, and Patient Education | $7,130,366 | $6,643,025 | 10% | |||
Professional Education and Scientific Programs | $8,586,010 | $6,534,163 | 9% | |||
Subtotal Program Services | $85,550,624 | $58,203,672 | 85% | |||
Member Services and Support Services | $7,039,520 | $6,051,308 | 9% | |||
Fundraising and Development | $4,354,087 | $4,599,587 | 7% | |||
Subtotal Supporting Services | $11,393,607 | $10,650,895 | 15% | |||
TOTAL EXPENSES | $96,944,231 | $68,854,567 | 100% | |||
Operating Surplus before Investments | ($9,427,267) | $4,515,622 | ||||
Other Changes | ||||||
Investment Income/(loss) | $20,719,012 | $16,869,187 | ||||
Nonrecurring Items | $18,474,463 | $13,082,380 | ||||
Subtotal Other Changes | $39,193,475 | $29,951,567 | ||||
Change in Unrestricted Net Assets | $29,766,208 | $34,467,189 | ||||
NET ASSETS BEGINNING OF YEAR | $91,037,751 | $120,803,959 | ||||
NET ASSETS END OF YEAR | $120,803,959 | $155,271,148 |